🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Clinical Trials Enhance Care for Advanced #GastrointestinalCancers Mike Pishvaian Johns Hopkins Kimmel Cancer Center hubs.li/Q03j7vFH0

Good morning from Charm City! Great to be back at Johns Hopkins Kimmel Cancer Center today for a #PancreaticCancer Think Tank and to celebrate the 20th year of the Sol Goldman pancreatic cancer research center. Here with Ralph Hruban Laura DeLong Wood Chris Iacobuzio Aatur Singhi, MD PhD Elliot K Fishman / CTisus.com Denis Wirtz

Johns Hopkins Kimmel Cancer Center researchers find unique immune responses among older adults receiving immune checkpoint inhibitors. bit.ly/4447hqk

Intratumoral heterogeneity drives therapy resistance in metastatic #ProstateCancer. Laura Sena Johns Hopkins Kimmel Cancer Center joins Andrea Miyahira Prostate Cancer Foundation discussing a detailed analysis of a patient's disease progression over seven years, Dr. Sena demonstrates how distinct cancer cell

Announcement: This just in! Chetan Bettegowda, the Jennison & Novak Families Professor of Neurosurgery, will lead the Johns Hopkins Department of Neurosurgery, as of 5/15. Henry Brem, MD, is stepping down after 25 years at the helm & we look forward to honoring him.

Crafting an Individual Treatment Plan for Patients With Prostate Cancer Johns Hopkins Kimmel Cancer Center #Oncology #ProstateCancer curetoday.com/view/crafting-…

Congratulations to Sandra Misale, PhD, recipient of the 2025 Cancer Discovery Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators. Learn more: brnw.ch/21wSfdp #AACR25 Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center AACR

Johns Hopkins Kimmel Cancer Center investigators devise novel AI-based blood test to detect brain cancers. hopkinsmedicine.org/news/newsroom/…

Benjamin Levy of Johns Hopkins Kimmel Cancer Center and Misty Dawn Shields of The Shields Lab discuss how the DeLLphi-301 trial demonstrated that tarlatamab achieved a 40% objective response rate in previously treated extensive-stage SCLC Watch the full discussion here: hubs.li/Q03lQY0m0

Joseph Murray, of @HopkinsKimmel and Johns Hopkins Medicine highlights positive treatment shifts that have shaped the BRAF V600E–mutant non–small cell lung cancer treatment paradigm. Read the full article here: hubs.li/Q03lRp6s0

Dr. Armine Smith, Johns Hopkins Kimmel Cancer Center, discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer. #BladderCancer #KidneyCancer Read more on the topic here: hubs.li/Q03mFp4M0

Disrupting tiny droplets that switch on cancer genes may be a strategy for treating a rare #kidneycancer known as translocation renal cell carcinoma (#tRCC), say researchers at Johns Hopkins Kimmel Cancer Center and @johnshopkinssph. bit.ly/3YO1PEy

Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function Johns Hopkins Kimmel Cancer Center #Oncology #KidneyCancer curetoday.com/view/robotic-k…

Can’t think of anymore more deserving of this than our former Johns Hopkins Kimmel Cancer Center #OncTwitter fellow, Dr. Ramy Sedhom, MD, FASCO. Congratulations!! 👏 👏 👏

Johns Hopkins Kimmel Cancer Center-developed technique to detect DNA shed by tumors could help clinicians determine if #pancreaticcancer therapies are working. bit.ly/43wCccX

🚨Hot off the press in MDPI Cancers: Oncology Biomarkers, Clinical Characteristics & Survival Outcomes in #Colorectal Cancer Patients w/ Spinal Metastases Undergoing Spinal Surgery: Insights from a Retrospective Cohort Study tinyurl.com/4bfa2wuv Hopkins Neurosurgery Spine

Congratulations, Sandra Misale, PhD, recipient of the 2025 Cancer Discovery Early Career Award. Dr. Misale is pictured with Editor-in-Chief Luis Diaz, MD. Learn more: brnw.ch/21wSXsr Johns Hopkins Medicine Johns Hopkins Kimmel Cancer Center

The future of GU oncology starts with insights from nirm, Cathy Handy Marshall, MD MPH, Jean Hoffman-Censits, Mohit Narang, MD, & Yasser Mohamed Ali Ged, MBBS at the Genitourinary Cancers #OncLiveSOSS on June 10th! Don't miss out! Register Now: hubs.li/Q03pLwPv0 Johns Hopkins Kimmel Cancer Center

Looking forward to a great line-up with GU onc experts from The Johns Hopkins Brady Urological Institute Johns Hopkins Kimmel Cancer Center Johns Hopkins Medicine Sibley Hospital JHM featuring Yasserged Cathy Handy Marshall, MD MPH Jean Hoffman-Censits Armine Smith & Mohit Narang. Dinner and great networking opportunity. Thank you MJH Life Sciences® OncLive.com !

Intratumoral heterogeneity drives therapy resistance in metastatic #ProstateCancer. Laura Sena Johns Hopkins Kimmel Cancer Center joins Andrea Miyahira Prostate Cancer Foundation discussing a detailed analysis of a patient's disease progression over seven years, Dr. Sena demonstrates how distinct cancer cell